10. Jubilarna Međunarodna Konferencija | 10th Jubilee International Conference BEZBEDNOST SAOBRAĆAJA U LOKALNOJ ZAJEDNICI ROAD SAFETY IN LOCAL COMMUNITIES Kragujevac, April, City of Kragujevac, April 22-25, Role of Drug Screening Technology to Improve European Road Safety Mark L. Johnson

Contents Road Accidents in the European Union Socio-Economic Impact of Road Accidents Potential Consequences of Drug Driving Characteristics of Leading Roadside Drug Screening Devices Results: Effective Technology to Reduce Drug Driving Fatalities Securetec AG

3 EU Safety Action Programme (2003) to halve road fatalities by 2010 was almost fully achieved. New Target: Reduce further 50% by Towards a European road safety area, policy orientations on road safety , European Commission, page 4 2. DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme , Final Report, European Commission February 2010, page 5 ² Road Accidents in the European Union

4 DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme , European Commission, Final Report, February 2010, page 8 Road Fatalities per Million Inhabitants in 2006 Road Accidents in the European Union: Fatalities per Million Gap between the best and worst performing Member State is large with the best performing 4 times better than the worst Road Accidents in the European Union

5 The estimated socio-economic costs in Europe are around €180 billion comprising 2% of GDP 1 The annual motor vehicle accident costs are approximately 20 billion Euros in the UK alone² The large number of road traffic deaths and injuries represents a substantial burden for the health sector in Member States³ 1.DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme , European Commission, Final Report, February 2010, page i 2.Baker Tilley report for Institute of Advanced Motoring, October 4th, 2011, 3.DG-TREN, Technical Assistance in support of the Preparation of the European Road Safety Action Programme ,, European Commission, Final Report, February 2010, page 5 Socio-Economic Impact of Road Accidents

6 The use of illicit drugs and some medicines, is an increasingly worrying factor in road accidents… If nothing is done urgently, there could soon be more accidents due to drugs than to alcohol. Different measures will have to be taken e.g.: Establishment of a harmonised procedure to detect illicit drugs in drivers Development of detection equipment… SAVING LIVES ON OUR ROADS, EUROPEAN ROAD SAFETY ACTION PROGRAMME, Halving the number of road accident victims in the European Union by 2010: A shared responsibility COMMUNICATION FROM THE COMMISSION COM(2003) 311 final, pages 20 & 21 Potential Consequences of Drug Driving

7 Why Test Oral Fluid? Saliva collection is much less invasive than urine collection When test person is not controlled during urine collection, sample can be manipulated and falsified Saliva sample reveals recent drug use Comparison of detectable THC traces in blood, saliva, urine after consumption Most often, legislation in Europe dictates: Saliva is tested at the roadside, blood for confirmation Characteristics of Leading Roadside Drug Screening Devices

8 The DRUID STUDY Sponsored by the European Commission, police officers evaluated failure rate, operability hygiene and technical performance of the most common oral fluid rapid tests - 36 institutions from 18 countries participated The study took place from 2006 – 2009 All data were independently gathered and assessed by Police and Universities in the EU and are publicly available The DRUID Study was defined in two parts: Part I: ESTHER – Evaluation of Easy Operation Part II: DRUID – Scientific Evaluation of Reliability ESTHER (Evaluation of oral Fluid Drug Screening devices by TISPOL to Harmonise European police Requirements DRUID (Driving under the Influence of Drugs) Characteristics of Leading Roadside Drug Screening Devices

9 Roadside Drug Screening Practice in Europe: DRUID Study Highlights Characteristics of Leading Roadside Drug Screening Devices Part I “ESTHER” on Practicability (2006 – 2009)

Solutions based on electronic readers 10 Part II “DRUID” Scientific Evaluation (2008 – 2009) Druid Project Deliverable from National Institute for Health and Welfare, Finland. Roadside Drug Screening Practice in Europe: DRUID Study Highlights Accuracy = 93% Characteristics of Leading Roadside Drug Screening Devices

11 Results in 3 to 8 minutes Very high sensitivity, specificity and accuracy Simple, fast and hygienic sampling (saliva) Very small saliva sample (e.g. obtainable in seconds, not minutes) Clear visible test lines Small, portable, robust, and versatile products (e.g. saliva, sweat, surfaces) No electronics necessary: Handheld electronic reading devices can be used as an option Characteristics of Leading Roadside Drug Screening Devices

Case Study in Australia Campaign: “Drivers tested: anybody, anywhere, anytime” reduced percentage of drug drivers involved in fatal accidents by half % of drivers involved in fatal accidents tested positively for drugs the Australian federal state of Victoria was the first region worldwide to establish a legal basis for drug control of vehicle operators which is not dependent on cause for suspicion The entire street is blocked and all drivers are tested for alcohol and drugs For Drug Screening, Securetec’s DrugWipe ® is applied % of the drivers who were involved in severe traffic accidents, tested positively for illegal drugs 2009 – Only 15% & 5th Australasian Drug Strategy Conference, Melbourne, Victoria in March 2010 Results: Effective Technology to Reduce Drug Driving Fatalities

Founded Employees Located near Munich, Germany Subsidiaries in the U.S. and in France Leading in the area of drug detection with worldwide sales in more than 30 countries on 5 continents In-house Research and Development Certified according to international standard ISO 9001 for quality management and the standard EN ISO for medical devices Introduction to Securetec AG 13 Detecting up to 6 Drug Substances Simultaneously Securetec AG

Conclusion EU member states and institutions widely recognize that drug driving significantly contributes to traffic accidents Several EU member states have already launched roadside drug screening programs which aim to reduce traffic accidents Technology can enable drug screening: There are devices available which are very easy-to-use and highly reliable Cooperation between industry and traffic police can only be achieved via national political will and relevant legislation

10. Jubilarna Međunarodna Konferencija | 10th Jubilee International Conference BEZBEDNOST SAOBRAĆAJA U LOKALNOJ ZAJEDNICI ROAD SAFETY IN LOCAL COMMUNITIES Kragujevac, April, City of Kragujevac, April 22-25, THANK YOU FOR YOUR ATTENTION …